Der Nuklearmediziner 2003; 26(3): 155-159
DOI: 10.1055/s-2003-44330
Nuklearmedizinische Nierendiagnostik

© Georg Thieme Verlag Stuttgart · New York

Radiopharmaka für die Nierenfunktionsdiagnostik

Radiopharmaceuticals for Renal Function ImagingW. Brandau1
  • 1Klinik für Nuklearmedizin, Arbeitsgruppe Nuklearchemie und Radiopharmazie, Universitätsklinikum Essen
Further Information

Publication History

Publication Date:
20 November 2003 (online)


[99mTc] Technetium ist aufgrund seiner optimalen physikalischen Eigenschaften für die Bildgebung das meistverwendete Radionuklid in der Nuklearmedizin. Es kann aber nur in Form von Metallkomplexen eingesetzt werden, deren in vivo Verhalten schwer vorhersagbar ist. In den letzten Jahren ist es jedoch durch systematische Variation einer Leitstruktur gelungen, Technetium-Radiopharmaka zu entwickeln, die renal aktiv transportiert werden. Dadurch kann einerseits neben der Glomerulären Filtrationsrate nun auch die Tubuläre Extraktionsrate quantifiziert werden, andererseits ist erstmals die Szintigraphie mit Technetium-markierten Substanzen möglich, die tubulär sezerniert werden.


Due to its favourable physical properties, [99mTc] Technetium is the mostly used radionuclide in nuclear medicine. It can only be used as metal complexes, whose pharmacokinetics cannot be predicted easily. By systematic variations of a known compound, Tc-complexes could be synthesized which are actively excreted by the kidneys. Thus, on the one hand, the tubular extraction rate can now be quantified in addition to the glomerular filtration rate and on the other hand, scintigraphic imaging is possible by the use of Tc-pharmaceuticals, which are eliminated by active tubular transport.


  • 1 Bianchi C, Blaufox M D. I-131-Hypaque and La-140-DTPA for the measurement of glomerular filtration in dog.  J Nucl med Biol Med. 1968;  12 117
  • 2 Bolt W, Lehnert G, Szadkowski D. Leberfunktionsprüfung mittels Radiodiodrast.  Med Klin. 1961;  56 1316
  • 3 Brandau W, Bubeck B, Eisenhut M, Steinbächer M, Georgi P, Reinbold F, Taylor D M. Preliminary Clinical Comparison of 99mTc-Mercaptoacetyl-triglycine and 131I-Orthoiodo-Hippuric Acid.  Nucl Med. 1986;  25 97-98
  • 4 Brandau W, Bubeck B, Eisenhut M, Taylor D M. Technetium-99m Labeled Renal Function and Imaging Agents: III. Synthesis of 99mTc MAG3 and Biodistribution of By-products.  Appl Radiat Isot. 1988;  19 121-129
  • 5 Bubeck B, Brandau W, Dreikorn K, Steinbächer M, Eisenhut M, zum Winkel K. Clinical Comparison of I-131 o-Iodohippurate with Tc-99m CO2-DADS-A and Tc-99m MAG3 by Simultaneous Double Tracer Measurement.  NucCompact. 1986;  17 135-138
  • 6 Bubeck B, Brandau W, Reinbold F, Dreikorn K, Steinbächer M, Eisenhut M, Georgi P. Technetium-99m Labeled Renal Function and Imaging Agents: I. Clinical Evaluation of 99mTc CO2-DADS-A (99mTc N,N′-Bis-(Mercaptoacetyl)-2,3-Diaminopropanoate).  Nucl Med Biol. 1988 a;  15 99-108
  • 7 Bubeck B, Brandau W, Steinbächer M, Reinbold F, Dreikorn K, Eisenhut M, Georgi P. Technetium-99m Labeled Renal Function and Imaging Agents: II. Clinical Evaluation of 99mTc MAG3 (99mTc Mercaptoacetylglycylglycylglycine).  Nucl Med Biol. 1988 b;  15 109-118
  • 8 Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P. Pharmakokinetics of Technetium-99m-MAG3 in Humans.  J Nucl Med. 1990;  31 1285-1293
  • 9 Bubeck B. Technetium-99m-MAG3 für die nuklearmedizinische Nierenfunktionsdiagnostik. Huber, Bern, Göttingen, Toronto, Seattle 1993
  • 10 Burbank M K, Tauxe W N, Maher F T, Hunt J C. Evaluation of radioiodinated hippuran for the estimation of renal plasma flow.  Mayo Clin Proc. 1961;  36 372-386
  • 11 Chassis H, Redish W, Goldring W. et al . The use of sodium p-aminohippurate for the functional evaluation of the human kidney.  J Clin Invest. 1945;  24 583-588
  • 12 Davison A, Sohn M, Orvig C, Jones A G, LaTegola M R. A tetradentate ligand designed specifically to coordinate technetium.  J Nucl Med. 1979;  20 641
  • 13 Davison A, Jones A G, Orvig C, Sohn M. A New Class of Oxotechnetium(5+)Chelate Complexes Containing a TcON2S2 Core.  Inorg Chem. 1981;  20 1629-1632
  • 14 Despopoulos A. A definition of substrate specifity in renal transport of organic anions.  J Theoret Biol. 1965;  8 163-192
  • 15 Dubovsky E V, Russell C D. 99mTc-MAG3: The Multipurpose Renal Radiopharmaceutical. In: Freeman LM. Nuclear Medicine Annual, Raven Press, New York 1991; 1-34
  • 16 Elwood C M, Sigman E M. The measurement of glomerular filtration and effective renal plasma flow in man by iothalamate-I131 and iodopyracet-I131.  Circulation. 1967;  36 441
  • 17 Eshima D, Fritzberg A R, Taylor A. 99mTc Renal Tubular Function Agents: Current Status.  Sem Nucl Med. 1990;  XX 28-40
  • 18 Fritzberg A R, Klingensmith W C, Whitney W P, Kuni C C. Chemical and Biological Studies of Tc-99m N,N′-Bis(mercaptoacetamido)ethylenediamine: A Potential Replacement for I-131 Iodohippurate.  J Nucl Med. 1981;  22 158-263
  • 19 Fritzberg A R, Whitney W P, Kuni C C, Klingensmith W C. Biodistribution and Renal Excretion of 99mTc-N,N′-bis-(Mercaptoacetamido) Ethylenediamine. Effect of Renal Tubular Transport Inhibitors.  Int J Med Biol. 1982 a;  9 79-82
  • 20 Fritzberg A R, Kuni C C, Klingensmith W C, Stevens J, Whitney W P. Synthesis and Biological Evaluation of Tc-99m N,N′-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement for [131I] o-iodohippurate.  J Nucl Med. 1982 b;  23 592-598
  • 21 Fritzberg A R, Kasina S, Johnson D L, Eshima D. Triamide Mercaptide (N 3S) Ligands for Tc-99m as Potential Tc-99m Renal Function Agents.  J Nucl Med. 1985;  26 19
  • 22 Fritzberg A R, Kasina S, Eshima D, Johnson D L. Synthesis and Biological Evaluation of Technetium-99m MAG3 as a Hippuran Replacement.  J Nucl Med. 1986;  27 111-116
  • 23 Johannsen B, Noll B, Heise K-H, May K, Syhre R, Strangfeld D, Bruch L, Modersohn D. Chemical and biological studies on the Technetium/S-unprotected MAG 3-System.  Med nucl. 1990;  2 115-123
  • 24 Jones A G, Davison A, LaTegola M R, Brodack W, Orvig C, Sohn M, Toothaker A K, Lock C JL, Franklin J, Costello C E, Carr S A, Biemann K, Kaplan M L. Chemical and In Vivo Studies of the Anion oxo[N,N′-ethylenebis(2-mercaptoacetimido)]Technetate(V).  J Nucl Med. 1982;  23 801-809
  • 25 Kasina S, Fritzberg A R, Johnson D L, Eshima D. Tissue Distribution Properties of Technetium-99m-Diamide-Dimercaptide Complexes and Potential Use as Renal Radiopharmaceuticals.  J Med Chem. 1986;  29 1933-1940
  • 26 Kimbel K H, Börner W. Über den Verbleib von J131-markiertem Urografin im Körper.  Nauyn-Schmiedebergs Arch Exp Path Pharmakol. 1955;  226 262-268
  • 27 Klingensmith W C, Fritzberg A R, Spitzer V M, Johnson D L, Kuni C C, Williamson M R, Washer G, Weil R. Clinical Evaluation of Tc-99m N,N′-Bis(mercaptoacetyl)-2,3-Diaminopropanoate as a Replacement for I-131 Hippurate: Concise Communication.  J Nucl Med. 1984;  25 42-48
  • 28 Lippman R W, Finkle R D, Gilette D. Effect of proteinuria on localization of radiomercury in rat kidney.  Proc Soc Exp Biol Med. 1951;  77 68
  • 29 Maher F T, Tauxe W N. Renal clearance in man of pharmaceuticals containing radioactive iodine. Influence of plasma binding.  JAMA. 1969;  207 97-104
  • 30 McAfee J G, Subramanian G, Schneider R F, Roskopf M, Lyons B, Ritter C, Zapf-Longo C, Palladino E, Thomas F D. Technetium-99m DADS Complexes as Renal Function and Imaging Agents: II. Biological Comparison with Iodine-131 Hippuran.  J Nucl Med. 1985;  26 375-386
  • 31 Nordyke R A, Tubis M, Blahd W H. Use of radioiodinated hippuran for individual kidney function test.  J Lab Clin Med. 1960;  56 438-445
  • 32 Oeser H, Billion H. Funktionelle Strahlendiagnostik durch etikettierte Röntgenkontrastmittel.  Fortschr Röntgenstr. 1952;  76 431-442
  • 33 Schneider R F, Subramanian G, Feld T A, McAfee J G, Zapf-Longo C, Palladino E, Thomas F D. N,N′-bis(S-Benzoylmercaptoacetamido)Ethylenediamine and Propylenediamine Ligands as Renal Function and Imaging Agents. I. Alternate Synthetic Methods.  J Nucl Med. 1984;  25 223-229
  • 34 Smith H W, Finkelstein N, Aliminosa L M. et al . Renal clearances of substituted hippuric acid derivatives and other aromatic acids in dogs and man.  J Clin Invest. 1945;  24 388-404
  • 35 Taplin G V, Meredith O M, Kade H, Winkler C C. The radioisotope renogram: an external test for individual kidney function and upper urinary tract patency.  J Lab Clin Med. 1956;  48 886-901
  • 36 Taylor A, Eshima D, Fritzberg A R, Christian P E, Kasina S. Comparison of Iodine-131 OIH and Technetium-99m MAG3 Renal Imaging in Volunteers.  J Nucl Med. 1986;  27 795-803
  • 37 Taylor A, Hansen L, Eshima D, Malveaux E, Folks R, Shattuck L, Lipowska M, Marzilli L G. Comparison of Technietium-99m-LL-EC Isomers in Rats and Humans.  J Nucl Med. 1997;  38 821-826
  • 38 Threefoot S A, Ray C T, Burch G E, Cronvich J A, Milnor J P, Overman W, Gordon W. Concentration-time course in the plasma of a man of radiomercury introduced as mercurail diuretic.  J Clin Invest. 1949;  28 661
  • 39 Tubis M, Posnick E, Nordyke R A. Preparation and use of I-131 labeled sodium iodohippurate in kidney function tests.  Proc Soc Exp Biol Med. 1960;  103 497-498
  • 40 Van Nerom C G, Bormans G M, De Roo M J, Verbruggen A M. First experience in healthy vounteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.  Eur J Nucl Med. 1993;  20 738-746
  • 41 Verbruggen A M, Nosco D L, Van Nerom C G, Bormans G M, Adiaens P J, De Roo M J. Technetium-99m-L,L-Ethylenedicysteine: A Renal Imaging Agent: I. Labeling and Evaluation in Animals.  J Nucl Med. 1992;  33 551-557
  • 42 Wellman H N, Berke R A, Robbins P J, Anger R T. Dynamic quantitative renal imaging with 123I-hippuran - a possible salvation of the renogram.  J Nucl Med. 1971;  12 405-406
  • 43 Winter C C. A clinical study of a new renal function test: the radioactive diodrast renogram.  J Urol. 1956;  76 182

Prof. Dr. W Brandau

Universitätsklinikum Essen

Nuklearchemie und Radiopharmazie

Hufelandstr. 55

D-45122 Essen

Phone: +49-2 01/7 23-41 72

Fax: +49-2 01/7 23-59 32